NRG-GI012 HELIO-RT - Clinical Trial

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT)
Principal Investigator
Manisha Palta, MD
Radiation Oncologist
Protocol Number
IRB: PRO00119729
NCT: NCT07166406
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Support Duke Health research or honor a loved one with a tribute gift.
Giving to Duke Health